Skip to main content
Top
Published in: Inflammation 4/2016

01-08-2016 | REVIEW

Review: the Multiple Roles of Monocytic Microparticles

Authors: Ahmad Tarmizi Abdul Halim, Nur Azrah Fazera Mohd Ariffin, Maryam Azlan

Published in: Inflammation | Issue 4/2016

Login to get access

Abstract

Monocytic microparticles (mMP) are microparticles derived from human monocytes either under in vivo or in vitro conditions. The size of mMP is between 0.1 and 1.0 μm. Apart from the size range, mMPs are also identified based on phosphatidylserine and CD14 expression on their surface, though this is not always the case. Monocytic MP are critical players in inflammation, endothelial cell function, and blood coagulation. They exhibit dual function by either helping the progression of such conditions or limiting it, depending on certain factors. Furthermore, the numbers of mMP are elevated in some autoimmune diseases, infectious diseases, and metabolic disorders. However, it is unknown whether mMP play an active role in these diseases or are simply biomarkers. The mechanism of mMP modulation is yet to be identified. In this review, we highlight the mechanism of mMP formation and the roles that they play in inflammation, blood coagulation, and different disease settings.
Literature
1.
go back to reference Wu, Z.H., et al. 2013. Membrane microparticles and diseases. European Review for Medical and Pharmacological Sciences 17(18): 2420–2427.PubMed Wu, Z.H., et al. 2013. Membrane microparticles and diseases. European Review for Medical and Pharmacological Sciences 17(18): 2420–2427.PubMed
2.
3.
go back to reference Bernimoulin, M., et al. 2009. Differential stimulation of monocytic cells results in distinct populations of microparticles. Journal of Thrombosis and Haemostasis 7(6): 1019–1028.CrossRefPubMedPubMedCentral Bernimoulin, M., et al. 2009. Differential stimulation of monocytic cells results in distinct populations of microparticles. Journal of Thrombosis and Haemostasis 7(6): 1019–1028.CrossRefPubMedPubMedCentral
4.
go back to reference Crompot, E., et al. 2015. Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: The importance of an appropriate negative control. PLoS One 10(5), e0127209.CrossRefPubMedPubMedCentral Crompot, E., et al. 2015. Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: The importance of an appropriate negative control. PLoS One 10(5), e0127209.CrossRefPubMedPubMedCentral
5.
go back to reference Wen, B., et al. 2014. Endotoxin-induced monocytic microparticles have contrasting effects on endothelial inflammatory responses. PLoS One 9(3), e91597.CrossRefPubMedPubMedCentral Wen, B., et al. 2014. Endotoxin-induced monocytic microparticles have contrasting effects on endothelial inflammatory responses. PLoS One 9(3), e91597.CrossRefPubMedPubMedCentral
6.
go back to reference Kanazawa, S., et al. 2003. Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. Lung Cancer 39(2): 145–149.CrossRefPubMed Kanazawa, S., et al. 2003. Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. Lung Cancer 39(2): 145–149.CrossRefPubMed
7.
go back to reference Batool, S., N. Abbasian, J.O. Burton, and C. Stover. 2013. Microparticles and their roles in inflammation: A review. The Open Immunology Journal 6: 14.CrossRef Batool, S., N. Abbasian, J.O. Burton, and C. Stover. 2013. Microparticles and their roles in inflammation: A review. The Open Immunology Journal 6: 14.CrossRef
9.
go back to reference Martinez, M.C., and R. Andriantsitohaina. 2011. Microparticles in angiogenesis: Therapeutic potential. Circulation Research 109(1): 110–119.CrossRefPubMed Martinez, M.C., and R. Andriantsitohaina. 2011. Microparticles in angiogenesis: Therapeutic potential. Circulation Research 109(1): 110–119.CrossRefPubMed
10.
go back to reference Kornek, M., et al. 2012. Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology 143(2): 448–458.CrossRefPubMedPubMedCentral Kornek, M., et al. 2012. Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology 143(2): 448–458.CrossRefPubMedPubMedCentral
11.
go back to reference Ziegler-Heitbrock, L., et al. 2010. Nomenclature of monocytes and dendritic cells in blood. Blood 116(16): e74–e80.CrossRefPubMed Ziegler-Heitbrock, L., et al. 2010. Nomenclature of monocytes and dendritic cells in blood. Blood 116(16): e74–e80.CrossRefPubMed
12.
go back to reference Angelillo-Scherrer, A. 2012. Leukocyte-derived microparticles in vascular homeostasis. Circulation Research 110(2): 356–369.CrossRefPubMed Angelillo-Scherrer, A. 2012. Leukocyte-derived microparticles in vascular homeostasis. Circulation Research 110(2): 356–369.CrossRefPubMed
13.
go back to reference Cerri, C., et al. 2006. Monocyte/macrophage-derived microparticles upregulate inflammatory mediator synthesis by human airway epithelial cells. Journal of Immunology 177(3): 1975–1980.CrossRef Cerri, C., et al. 2006. Monocyte/macrophage-derived microparticles upregulate inflammatory mediator synthesis by human airway epithelial cells. Journal of Immunology 177(3): 1975–1980.CrossRef
14.
go back to reference Del Conde, I., et al. 2005. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106(5): 1604–1611.CrossRefPubMed Del Conde, I., et al. 2005. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106(5): 1604–1611.CrossRefPubMed
15.
go back to reference Liu, M.L., et al. 2007. Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles. Arteriosclerosis, Thrombosis, and Vascular Biology 27(2): 430–435.CrossRefPubMed Liu, M.L., et al. 2007. Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles. Arteriosclerosis, Thrombosis, and Vascular Biology 27(2): 430–435.CrossRefPubMed
16.
go back to reference Neri, T., et al. 2011. Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles. European Respiratory Journal 37(6): 1494–1502.CrossRefPubMed Neri, T., et al. 2011. Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles. European Respiratory Journal 37(6): 1494–1502.CrossRefPubMed
18.
go back to reference Bardelli, C., et al. 2012. Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARgamma ligands. British Journal of Pharmacology 165(3): 716–728.CrossRefPubMedPubMedCentral Bardelli, C., et al. 2012. Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARgamma ligands. British Journal of Pharmacology 165(3): 716–728.CrossRefPubMedPubMedCentral
19.
go back to reference Mastronardi, M.L., et al. 2011. Microparticles from apoptotic monocytes enhance nitrosative stress in human endothelial cells. Fundamental and Clinical Pharmacology 25(6): 653–660.CrossRefPubMed Mastronardi, M.L., et al. 2011. Microparticles from apoptotic monocytes enhance nitrosative stress in human endothelial cells. Fundamental and Clinical Pharmacology 25(6): 653–660.CrossRefPubMed
21.
go back to reference Eyre, J., et al. 2011. Monocyte- and endothelial-derived microparticles induce an inflammatory phenotype in human podocytes. Nephron Experimental Nephrology 119(3): e58–e66.CrossRefPubMed Eyre, J., et al. 2011. Monocyte- and endothelial-derived microparticles induce an inflammatory phenotype in human podocytes. Nephron Experimental Nephrology 119(3): e58–e66.CrossRefPubMed
22.
go back to reference Novo, E., and M. Parola. 2008. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis & Tissue Repair 1(1): 5.CrossRef Novo, E., and M. Parola. 2008. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis & Tissue Repair 1(1): 5.CrossRef
23.
go back to reference Dignat-George, F., and C.M. Boulanger. 2011. The many faces of endothelial microparticles. Arteriosclerosis, Thrombosis, and Vascular Biology 31(1): 27–33.CrossRefPubMed Dignat-George, F., and C.M. Boulanger. 2011. The many faces of endothelial microparticles. Arteriosclerosis, Thrombosis, and Vascular Biology 31(1): 27–33.CrossRefPubMed
24.
go back to reference Aleman, M.M., et al. 2011. Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. Journal of Thrombosis and Haemostasis 9(11): 2251–2261.CrossRefPubMedPubMedCentral Aleman, M.M., et al. 2011. Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. Journal of Thrombosis and Haemostasis 9(11): 2251–2261.CrossRefPubMedPubMedCentral
25.
go back to reference Robinson, R.A., L. Worfolk, and P.B. Tracy. 1992. Endotoxin enhances the expression of monocyte prothrombinase activity. Blood 79(2): 406–416.PubMed Robinson, R.A., L. Worfolk, and P.B. Tracy. 1992. Endotoxin enhances the expression of monocyte prothrombinase activity. Blood 79(2): 406–416.PubMed
26.
go back to reference Satta, N., J.M. Freyssinet, and F. Toti. 1997. The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide. British Journal of Haematology 96(3): 534–542.CrossRefPubMed Satta, N., J.M. Freyssinet, and F. Toti. 1997. The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide. British Journal of Haematology 96(3): 534–542.CrossRefPubMed
27.
go back to reference Falati, S., et al. 2003. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. Journal of Experimental Medicine 197(11): 1585–1598.CrossRefPubMedPubMedCentral Falati, S., et al. 2003. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. Journal of Experimental Medicine 197(11): 1585–1598.CrossRefPubMedPubMedCentral
28.
go back to reference Li, M., et al. 2010. Tobacco smoke induces the generation of procoagulant microvesicles from human monocytes/macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology 30(9): 1818–1824.CrossRefPubMedPubMedCentral Li, M., et al. 2010. Tobacco smoke induces the generation of procoagulant microvesicles from human monocytes/macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology 30(9): 1818–1824.CrossRefPubMedPubMedCentral
29.
go back to reference Williams, J.C., et al. 2015. Delta(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles. Journal of Inflammation (London) 12: 39.CrossRef Williams, J.C., et al. 2015. Delta(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles. Journal of Inflammation (London) 12: 39.CrossRef
30.
go back to reference Khan, M.M., et al. 2010. Upregulation of tissue factor in monocytes by cleaved high molecular weight kininogen is dependent on TNF-alpha and IL-1beta. American Journal of Physiology - Heart and Circulatory Physiology 298(2): H652–H658.CrossRefPubMed Khan, M.M., et al. 2010. Upregulation of tissue factor in monocytes by cleaved high molecular weight kininogen is dependent on TNF-alpha and IL-1beta. American Journal of Physiology - Heart and Circulatory Physiology 298(2): H652–H658.CrossRefPubMed
31.
go back to reference Bajaj, M.S., M. Ghosh, and S.P. Bajaj. 2007. Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: Physiologic and pathologic implications. Journal of Thrombosis and Haemostasis 5(7): 1493–1499.CrossRefPubMed Bajaj, M.S., M. Ghosh, and S.P. Bajaj. 2007. Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: Physiologic and pathologic implications. Journal of Thrombosis and Haemostasis 5(7): 1493–1499.CrossRefPubMed
32.
go back to reference Hoyer, F.F., et al. 2012. Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice. Journal of Cellular and Molecular Medicine 16(11): 2777–2788.CrossRefPubMedPubMedCentral Hoyer, F.F., et al. 2012. Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice. Journal of Cellular and Molecular Medicine 16(11): 2777–2788.CrossRefPubMedPubMedCentral
33.
go back to reference Nomura, S., S. Kanazawa, and S. Fukuhara. 2002. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. Journal of Human Hypertension 16(8): 539–547.CrossRefPubMed Nomura, S., S. Kanazawa, and S. Fukuhara. 2002. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. Journal of Human Hypertension 16(8): 539–547.CrossRefPubMed
34.
go back to reference Hjuler Nielsen, M., et al. 2015. Elevated atherosclerosis-related gene expression, monocyte activation and microparticle-release are related to increased lipoprotein-associated oxidative stress in familial hypercholesterolemia. PLoS One 10(4), e0121516.CrossRefPubMedPubMedCentral Hjuler Nielsen, M., et al. 2015. Elevated atherosclerosis-related gene expression, monocyte activation and microparticle-release are related to increased lipoprotein-associated oxidative stress in familial hypercholesterolemia. PLoS One 10(4), e0121516.CrossRefPubMedPubMedCentral
35.
go back to reference Omoto, S., et al. 2002. Detection of monocyte-derived microparticles in patients with type II diabetes mellitus. Diabetologia 45(4): 550–555.CrossRefPubMed Omoto, S., et al. 2002. Detection of monocyte-derived microparticles in patients with type II diabetes mellitus. Diabetologia 45(4): 550–555.CrossRefPubMed
36.
go back to reference Ogata, N., et al. 2006. Elevation of monocyte-derived microparticles in patients with diabetic retinopathy. Diabetes Research and Clinical Practice 73(3): 241–248.CrossRefPubMed Ogata, N., et al. 2006. Elevation of monocyte-derived microparticles in patients with diabetic retinopathy. Diabetes Research and Clinical Practice 73(3): 241–248.CrossRefPubMed
37.
go back to reference Pankoui Mfonkeu, J.B., et al. 2010. Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria. PLoS One 5(10), e13415.CrossRefPubMedPubMedCentral Pankoui Mfonkeu, J.B., et al. 2010. Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria. PLoS One 5(10), e13415.CrossRefPubMedPubMedCentral
38.
go back to reference Idro, R., et al. 2010. Cerebral malaria: Mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatric Research 68(4): 267–274.CrossRefPubMedPubMedCentral Idro, R., et al. 2010. Cerebral malaria: Mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatric Research 68(4): 267–274.CrossRefPubMedPubMedCentral
39.
go back to reference John, C.C., et al. 2008. Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. American Journal of Tropical Medicine and Hygiene 78(2): 198–205.PubMedPubMedCentral John, C.C., et al. 2008. Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. American Journal of Tropical Medicine and Hygiene 78(2): 198–205.PubMedPubMedCentral
40.
go back to reference Mack, M., et al. 2000. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection. Nature Medicine 6(7): 769−775.CrossRefPubMed Mack, M., et al. 2000. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection. Nature Medicine 6(7): 769−775.CrossRefPubMed
41.
go back to reference Distler, J.H., et al. 2005. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proceedings of the National Academy of Sciences of the United States of America 102(8): 2892–2897.CrossRefPubMedPubMedCentral Distler, J.H., et al. 2005. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proceedings of the National Academy of Sciences of the United States of America 102(8): 2892–2897.CrossRefPubMedPubMedCentral
42.
go back to reference Takeshita, J., et al. 2014. Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors. Journal of the American Heart Association 3(1), e000507.CrossRefPubMedPubMedCentral Takeshita, J., et al. 2014. Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors. Journal of the American Heart Association 3(1), e000507.CrossRefPubMedPubMedCentral
43.
go back to reference Patel, R.V., et al. 2011. Psoriasis and vascular disease-risk factors and outcomes: A systematic review of the literature. Journal of General Internal Medicine 26(9): 1036–1049.CrossRefPubMedPubMedCentral Patel, R.V., et al. 2011. Psoriasis and vascular disease-risk factors and outcomes: A systematic review of the literature. Journal of General Internal Medicine 26(9): 1036–1049.CrossRefPubMedPubMedCentral
44.
go back to reference Baka, Z., et al. 2010. Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis. Immunology Letters 128(2): 124–130.CrossRefPubMed Baka, Z., et al. 2010. Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis. Immunology Letters 128(2): 124–130.CrossRefPubMed
45.
go back to reference Nagahama, M., et al. 2003. Significance of anti-oxidized LDL antibody and monocyte-derived microparticles in anti-phospholipid antibody syndrome. Autoimmunity 36(3): 125–131.CrossRefPubMed Nagahama, M., et al. 2003. Significance of anti-oxidized LDL antibody and monocyte-derived microparticles in anti-phospholipid antibody syndrome. Autoimmunity 36(3): 125–131.CrossRefPubMed
46.
go back to reference Crookston, K.P., et al. 2013. Circulating microparticles in neuropsychiatric systemic lupus erythematosus. International Journal of Rheumatic Diseases 16(1): 72–80.CrossRefPubMed Crookston, K.P., et al. 2013. Circulating microparticles in neuropsychiatric systemic lupus erythematosus. International Journal of Rheumatic Diseases 16(1): 72–80.CrossRefPubMed
47.
go back to reference George, F.D. 2008. Microparticles in vascular diseases. Thrombosis Research 122(Suppl 1): S55–S59.CrossRefPubMed George, F.D. 2008. Microparticles in vascular diseases. Thrombosis Research 122(Suppl 1): S55–S59.CrossRefPubMed
Metadata
Title
Review: the Multiple Roles of Monocytic Microparticles
Authors
Ahmad Tarmizi Abdul Halim
Nur Azrah Fazera Mohd Ariffin
Maryam Azlan
Publication date
01-08-2016
Publisher
Springer US
Published in
Inflammation / Issue 4/2016
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0381-8

Other articles of this Issue 4/2016

Inflammation 4/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.